NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1010 coverApoptosis from Signaling Pathways to Therapeutic Tools Volume 1010 published December 2003
Ann. N.Y. Acad. Sci. 1010: 520–524 (2003). doi: 10.1196/annals.1299.096
Copyright © 2003 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via Google Scholar
Google Scholar
Articles by CERMAN, J.
Articles by CERVINKA, M.
Search for Related Content
PubMed
PubMed Citation
Articles by CERMAN, J.
Articles by CERVINKA, M.
The Role of Apoptosis in Pituitary Adenomas in the Field of Conventionally Used Therapeutic Approaches

JAROSLAV CERMANa, JAN CAPb, MARTINA MAREKOVAa, STANISLAV NEMECEKc, JOSEF MAREKe, EMIL RUDOLFd AND MIROSLAV CERVINKAd

aDepartment of Medical Biochemistry, b2nd Department of Internal Medicine, cDepartment of Neurosurgery, dDepartment of Medical Biology and Genetics, Charles University in Prague, Faculty of Medicine in Hradec Kralove, 500 38 Hradec Kralove, Czech Republic
e3rd Department of Internal Medicine in Prague, Charles University in Prague, Prague, Czech Republic

Address for correspondence: Jaroslav Cerman, Department of Medical Biochemistry, Charles University in Prague, Faculty of Medicine in Hradec Kralove, P.O. Box 38, 500 38 Hradec Kralove, Czech Republic. Voice: +420-495816222; fax: +420-495513597. cerman{at}lfhk.cuni.cz
Ann. N.Y. Acad. Sci. 1010: 520-524 (2003).

The aim of the study was to investigate the mechanism of action of somatostatin analogues (SSA), ionizing radiation, and their combination on pituitary adenoma cells with special emphasis on proliferative and apoptotic activity. In the 14 GH-secreting adenomas pretreated with SSA before surgery, more prominent regressive changes were found accompanied by compensatory increase in perivascular fibrosis than in the reference group of 17 unpretreated adenomas. The proliferative Ki-67 labeling index was significantly lower in the treated group (median 1.6 per 1000) than in the untreated patients (median 5.0 per 1000). Apoptosis was detected in only 2 of the 14 pretreated adenomas, and it was more frequent (9/17) and more prominent in the untreated group. In cell lines, the SSA had minimal antiproliferative effect, and they were unable to induce apoptosis. Ionizing radiation at doses of 5-20 Gy induced apoptosis in the corticotroph cell line AtT20 with no cell-cycle block. In the somatotroph GH3 cell line, the early (premitotic) apoptosis was detectable using only a high dose of 200 Gy; after irradiation with doses of 20-50 Gy, apoptosis appeared with the latency of 48-72 hours, and was preceded by cell-cycle arrest in the G2/M phase. The treatment with somatostatin-14 during irradiation increased the percentage of apoptotic cells in culture 10 days after irradiation (11% versus 3% using 20 Gy).

Key Words: apoptosis • pituitary adenomas • acromegaly • somatostatin analogues • irradiation • cell lines






footerLeft footerRight